Effect of systemic adjuvant treatment on first sites of breast cancer relapse

[1]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[2]  F. Cavalli,et al.  Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer , 1991 .

[3]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[4]  F. Cavalli,et al.  METHOTREXATE/NITROUS-OXIDE TOXIC INTERACTION IN PERIOPERATIVE CHEMOTHERAPY FOR EARLY BREAST CANCER , 1987, The Lancet.

[5]  J. Silber,et al.  CHEMOENDOCRINE VERSUS ENDOCRINE THERAPY IN BREAST CANCER , 1984, The Lancet.

[6]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[7]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[8]  I. Henderson,et al.  Cancer of the breast: the past decade (first of two parts). , 1980, The New England journal of medicine.

[9]  G. Friedell,et al.  Identification of breast cancer patients with high risk of early recurrence after radical mastectomy. II. Clinical and pathological correlations , 1978, Cancer.

[10]  Donegan Wl Patterns and prognosis of advanced breast carcinoma. , 1970 .

[11]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[12]  R. Gelber,et al.  A single perioperative adjuvant chemotherapy course for node-negative breast cancer: five-year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group). , 1992, Journal of the National Cancer Institute. Monographs.

[13]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .

[14]  M. Zelen,et al.  Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. , 1989, The New England journal of medicine.

[15]  R. Gray A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[16]  R. Gelber,et al.  Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Gelber,et al.  Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. , 1986, NCI monographs : a publication of the National Cancer Institute.

[18]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .